Seres Therapeutics, Inc. ($MCRB)
Filing Information
| Accession Number | 0001193125-26-230732 |
|---|---|
| Form Type | 4 |
| Filing Date | May 19, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
419
Total Value
$444.27
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer, EVP | Common Stock | โ | May 15, 2026 | Exercise/Conversion | 180 | โ | โ | 8,621 | Direct | โ | View Details | |
Chief Operating Officer, EVP | Common Stock | โ | May 18, 2026 | Sale | 59 | $7.53 | $444.27 | 8,562 | Direct | โ | View Details | |
Chief Operating Officer, EVP | Restricted Stock Units | Derivative | May 15, 2026 | Exercise/Conversion | 89 | $0.00 | $0.00 | 269 | Direct | โ | View Details | |
Chief Operating Officer, EVP | Restricted Stock Units | Derivative | May 15, 2026 | Exercise/Conversion | 91 | $0.00 | $0.00 | 639 | Direct | โ | View Details |